€3.13
1.88% today
L&S, Jul 02, 10:18 pm CET
ISIN
CA94947L1022
Symbol
WELL

WELL Health Technologies Target price 2024 - Analyst rating & recommendation

WELL Health Technologies Classifications & Recommendation:

Buy
93%
Hold
7%

WELL Health Technologies Target price

Target price CAD7.60
Course CAD4.71
Price potential
Number of estimates 15
15 Analysts have issued a price target WELL Health Technologies 2025 . The average WELL Health Technologies target price is CAD7.60. This is higher than the current share price. The highest price target is
CAD10.00 112.31%
register free of charge
, the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend WELL Health Technologies to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the WELL Health Technologies share has an average upside potential 2025 of . Most analysts recommend the WELL Health Technologies share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million CAD 776.05 973.27
36.35% 25.41%
EBITDA margin 13.13% 13.10%
8.52% 0.21%
Net margin 0.00% 0.83%
100.00%

15 Analysts have issued a sales forecast WELL Health Technologies 2024 . The average WELL Health Technologies sales estimate is

CAD973m
Unlock
. This is
16.12% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
CAD987m 17.75%
Unlock
, the lowest is
CAD962m 14.81%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 CAD776m 36.35%
2024
CAD973m 25.41%
Unlock
2025
CAD1.1b 9.93%
Unlock
2026
CAD1.2b 8.14%
Unlock
2027
CAD1.2b 3.23%
Unlock
2028
CAD1.4b 13.91%
Unlock

14 Analysts have issued an WELL Health Technologies EBITDA forecast 2024. The average WELL Health Technologies EBITDA estimate is

CAD127m
Unlock
. This is
18.25% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD129m 19.86%
Unlock
, the lowest is
CAD126m 16.62%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 CAD102m 24.73%
2024
CAD127m 25.11%
Unlock
2025
CAD149m 17.02%
Unlock
2026
CAD147m 1.18%
Unlock
2027
CAD152m 3.05%
Unlock

EBITDA margin

2023 13.13% 8.52%
2024
13.10% 0.21%
Unlock
2025
13.94% 6.41%
Unlock
2026
12.74% 8.61%
Unlock
2027
12.72% 0.16%
Unlock

7 WELL Health Technologies Analysts have issued a net profit forecast 2024. The average WELL Health Technologies net profit estimate is

CAD8.1m
Unlock
. This is
72.62% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD27.0m 8.33%
Unlock
, the lowest is
CAD-31.9m 208.33%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 CAD0.0 100.00%
2025
CAD16.0m 97.89%
Unlock
2026
CAD86.0m 438.32%
Unlock

Net margin

2023 0.00% 100.00%
2025
1.49% 79.52%
Unlock
2026
7.43% 398.66%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share CAD 0.00 0.03
100.00%
P/E ratio 143.35
EV/Sales 1.66

7 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies <a href=/blog/eps>EPS is

CAD0.03
Unlock
. This is
75.00% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
CAD0.11 8.33%
Unlock
, the lowest is
CAD-0.13 208.33%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 CAD0.00 100.00%
2025
CAD0.07 133.33%
Unlock
2026
CAD0.35 400.00%
Unlock

P/E ratio

Current 38.83 116.08%
2024
143.35 269.17%
Unlock
2025
72.46 49.45%
Unlock
2026
13.46 81.42%
Unlock

Based on analysts' sales estimates for 2024, the WELL Health Technologies share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.93 22.49%
2024
1.66 13.79%
Unlock
2025
1.51 9.03%
Unlock
2026
1.40 7.53%
Unlock
2027
1.36 3.13%
Unlock
2028
1.19 12.21%
Unlock

P/S ratio

Current 1.38 24.30%
2024
1.19 13.88%
Unlock
2025
1.08 9.03%
Unlock
2026
1.00 7.52%
Unlock
2027
0.97 3.13%
Unlock
2028
0.85 12.22%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today